INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,396 | +67.6% | 345 | 0.0% | 0.00% | – |
| Q2 2023 | $3,816 | +76220.0% | 345 | -6.0% | 0.00% | – |
| Q1 2023 | $5 | 0.0% | 367 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 367 | +6.4% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 345 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 345 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | 0.0% | 345 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -90.0% | 345 | -91.5% | 0.00% | – |
| Q3 2021 | $60,000 | -25.9% | 4,045 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $81,000 | +912.5% | 4,045 | +1072.5% | 0.00% | – |
| Q1 2021 | $8,000 | -11.1% | 345 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | -82.0% | 345 | -71.1% | 0.00% | – |
| Q3 2020 | $50,000 | +455.6% | 1,195 | +512.8% | 0.00% | – |
| Q2 2020 | $9,000 | -18.2% | 195 | +8.3% | 0.00% | – |
| Q1 2020 | $11,000 | -70.3% | 180 | -40.0% | 0.00% | – |
| Q4 2019 | $37,000 | +428.6% | 300 | +200.0% | 0.00% | – |
| Q3 2019 | $7,000 | -12.5% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -27.3% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | +10.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $10,000 | -23.1% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |